AD Biomarkers Change Similarly Before Symptoms
Explore how two major studies confirm the progression of Alzheimer’s biomarkers, from amyloid to tau, over 20 years leading to diagnosis.
Explore how two major studies confirm the progression of Alzheimer’s biomarkers, from amyloid to tau, over 20 years leading to diagnosis.
Watch a recording of the Dementias Platform UK Great Minds event, with a stellar line-up of speakers discussing new treatments for dementia.
Dive into Dr Gaia Brezzo’s blog on FACS, a key immunology tool. Learn the difference between FACS & flow cytometry, and its impact on cellular research.
Catch-up on the most recent ARUK Lab Notes session to hear from Dr Louise Kelly and Dr Jake Brooks talk about Air Pollution and Dementia.
Would carrying a muted version of APOE4, the strongest genetic risk factor of sporadic Alzheimer’s disease, protect against the disorder? Alz Forum explores
Volunteering in late life is associated with better cognitive function, better executive function & episodic memory, according to research presented at the AAIC
Experiencing less frequent bowel movements is associated with cognitive decline, according to new research reported today at the AAIC
Research reported at AAIC shows a simple, finger prick blood test shows promise in the ability to detect Alzheimer’s disease.
New Research from AAIC reports on the largest clinical trial to investigate whether a hearing loss treatment intervention can reduce risk of cognitive decline.
New Research presented at the AAIC shows new opioid use in older adults with dementia is associated with a significantly increased risk of death.
New Research presented at the AAIC shows provide details on two new CRISPR-based strategies which offer hope for next-generation Alzheimer’s treatments.
Talks from a special webinar hosted by the UK Dementia Research Institute exploring opportunities to harness the UK Biobank’s data resources for your research.